Published in J Biol Chem on January 23, 1998
Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry. EMBO J (2000) 2.14
The RNA binding protein nuclear factor 90 functions as both a positive and negative regulator of gene expression in mammalian cells. Mol Cell Biol (2002) 1.39
DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks. DNA Repair (Amst) (2008) 1.29
Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90/110 involved in mitotic control. Mol Cell Biol (2008) 1.26
Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol (2008) 1.12
Phosphorylation of eukaryotic translation initiation factor 2alpha coordinates rRNA transcription and translation inhibition during endoplasmic reticulum stress. Mol Cell Biol (2009) 1.10
Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells. Nucleic Acids Res (2007) 1.10
NF90 regulates inducible IL-2 gene expression in T cells. J Exp Med (2007) 1.07
NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response. Cell Death Differ (2009) 1.01
The dynamic stress-induced "O-GlcNAc-ome" highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways. Amino Acids (2010) 0.98
HIV-1 replication and latency are regulated by translational control of cyclin T1. J Mol Biol (2011) 0.97
The DNA-dependent protein kinase: A multifunctional protein kinase with roles in DNA double strand break repair and mitosis. Prog Biophys Mol Biol (2014) 0.96
Transcription factor proteomics: identification by a novel gel mobility shift-three-dimensional electrophoresis method coupled with southwestern blot and high-performance liquid chromatography-electrospray-mass spectrometry analysis. J Chromatogr A (2011) 0.95
The NF90/NF45 complex participates in DNA break repair via nonhomologous end joining. Mol Cell Biol (2011) 0.93
The N-terminal domain of the human eIF2beta subunit and the CK2 phosphorylation sites are required for its function. Biochem J (2006) 0.92
A new double-stranded RNA-binding protein that interacts with PKR. Nucleic Acids Res (2000) 0.87
A multiprotein complex necessary for both transcription and DNA replication at the β-globin locus. EMBO J (2010) 0.86
Nuclear factor NF45 interacts with viral proteins of infectious bursal disease virus and inhibits viral replication. J Virol (2010) 0.85
NF90 in posttranscriptional gene regulation and microRNA biogenesis. Int J Mol Sci (2013) 0.85
The translation initiation factor eIF2beta is an interactor of protein phosphatase-1. Biochem J (2006) 0.82
Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability. Oncogene (2014) 0.82
RNA granule assembly and disassembly modulated by nuclear factor associated with double-stranded RNA 2 and nuclear factor 45. J Biol Chem (2014) 0.81
Global proteomics analysis of testis and ovary in adult zebrafish (Danio rerio). Fish Physiol Biochem (2011) 0.79
Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation. F1000Res (2014) 0.79
An Intrinsically Disordered APLF Links Ku, DNA-PKcs and XRCC4-DNA Ligase IV in an Extended Flexible Non-Homologous End Joining Complex. J Biol Chem (2016) 0.78
The NF45/NF90 Heterodimer Contributes to the Biogenesis of 60S Ribosomal Subunits and Influences Nucleolar Morphology. Mol Cell Biol (2015) 0.78
Phosphorylation of human eukaryotic initiation factor 2γ: novel site identification and targeted PKC involvement. J Proteome Res (2011) 0.78
L-Ilf3 and L-NF90 traffic to the nucleolus granular component: alternatively-spliced exon 3 encodes a nucleolar localization motif. PLoS One (2011) 0.78
Identification of Plasmodium falciparum Translation Initiation eIF2β Subunit: Direct Interaction with Protein Phosphatase Type 1. Front Microbiol (2016) 0.78
High expression of nuclear factor 90 (NF90) leads to mitochondrial degradation in skeletal and cardiac muscles. PLoS One (2012) 0.76
The RNA Binding Complexes NF45-NF90 and NF45-NF110 Associate Dynamically with the c-fos Gene and Function as Transcriptional Coactivators. J Biol Chem (2015) 0.76
Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim Biophys Acta (2016) 0.76
Phosphorylation at serine 482 affects stability of NF90 and its functional role in mitosis. Cell Prolif (2011) 0.76
Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma. Int J Mol Sci (2016) 0.75
An integrated map of HIV-human protein complexes that facilitate viral infection. PLoS One (2014) 0.75
DNA-PKcs controls calcineurin mediated IL-2 production in T lymphocytes. PLoS One (2017) 0.75
UGGT1 enhances enterovirus 71 pathogenicity by promoting viral RNA synthesis and viral replication. PLoS Pathog (2017) 0.75
Natural history of progression after PSA elevation following radical prostatectomy. JAMA (1999) 14.35
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA (1992) 6.40
DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell (1995) 4.64
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol (1993) 4.55
Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science (1995) 4.19
ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet (1998) 3.66
Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol (1999) 2.93
The DNA-dependent protein kinase is inactivated by autophosphorylation of the catalytic subunit. J Biol Chem (1996) 2.92
Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J Biol Chem (2000) 2.42
Hepatitis B and hepatitis C in emergency department patients. N Engl J Med (1992) 2.39
Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging. Urology (2001) 2.38
Laboratory and bedside evaluation of portable glucose meters. Am J Clin Pathol (1995) 2.35
Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities. Mol Cell Biol (2000) 2.21
Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site. J Biol Chem (1984) 2.17
Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol (2001) 2.07
The nuclear serine/threonine protein kinase DNA-PK. Crit Rev Eukaryot Gene Expr (1992) 2.05
Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J Biol Chem (2001) 2.02
DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J (1996) 1.97
Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum (1998) 1.92
Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues. J Biol Chem (1986) 1.90
Protein phosphatases regulate DNA-dependent protein kinase activity. J Biol Chem (2001) 1.89
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol (1988) 1.81
Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest (1999) 1.80
Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer. JAMA (1997) 1.80
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer. Urology (1997) 1.79
Purification and characterization of the double-stranded DNA-activated protein kinase, DNA-PK, from human placenta. Biochem Cell Biol (1996) 1.75
Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem (1999) 1.72
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol (2000) 1.72
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol (1998) 1.69
DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature (1998) 1.68
Immunosensors--principles and applications to clinical chemistry. Clin Chim Acta (2001) 1.66
Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene (1993) 1.63
Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats. Am J Respir Crit Care Med (2000) 1.59
Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelity. J Biol Chem (2001) 1.57
Tra1p is a component of the yeast Ada.Spt transcriptional regulatory complexes. J Biol Chem (1998) 1.55
PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J Biol Chem (1999) 1.50
Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3. J Biol Chem (2000) 1.49
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol (1990) 1.49
Purification by DNA affinity chromatography of two polypeptides that contact the NF-AT DNA binding site in the interleukin 2 promoter. J Biol Chem (1994) 1.43
Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol (1998) 1.40
Tick-borne pulmonary disease: update on diagnosis and management. Chest (1999) 1.39
DNA-dependent protein kinase phosphorylation sites in Ku 70/80 heterodimer. Biochemistry (1999) 1.38
Identifying markers for pancreatic cancer by gene expression analysis. Cancer Epidemiol Biomarkers Prev (1998) 1.36
Nuclear factor-90 of activated T-cells: A double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR. Biochemistry (1999) 1.33
Cationic ferritin changes outflow facility in human eyes whereas anionic ferritin does not. Invest Ophthalmol Vis Sci (2001) 1.33
Relative affinities of poly(ADP-ribose) polymerase and DNA-dependent protein kinase for DNA strand interruptions. Biochim Biophys Acta (1999) 1.27
Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine. J Biol Chem (2001) 1.27
Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. Histopathology (2007) 1.27
Reliability, validity and the structure of the General Health Questionnaire in a Chinese context. Psychol Med (1983) 1.24
Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase. J Biol Chem (2000) 1.24
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol (1989) 1.20
Influence of radical prostatectomy on serum hormone levels. J Urol (1998) 1.19
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. Clin Chem (1987) 1.19
Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models. Prostate (2001) 1.17
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis. Urology (1999) 1.16
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res (1992) 1.15
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays. J Proteome Res (2010) 1.13
Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer. Anticancer Res (2001) 1.13
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology (1996) 1.12
Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett (2001) 1.10
Lack of correlation between DNA-dependent protein kinase activity and tumor cell radiosensitivity. Cancer Res (1995) 1.10
Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia. Am J Obstet Gynecol (1994) 1.09
Meaning of serum free-thyroxin values in nonthyroidal illnesses: seven methods compared. Clin Chem (1983) 1.08
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity. Urology (1995) 1.08
The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner. J Biol Chem (2000) 1.07
Potassium currents in freshly dissociated uterine myocytes from nonpregnant and late-pregnant rats. J Gen Physiol (1998) 1.05
Acute renal failure after eating raw fish gall bladder. Br Med J (Clin Res Ed) (1985) 1.05
Lack of correlation between ATM protein expression and tumour cell radiosensitivity. Int J Radiat Biol (1998) 1.03
The human DNA-activated protein kinase phosphorylates simian virus 40 T antigen at amino- and carboxy-terminal sites. J Virol (1991) 1.02
NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response. Cell Death Differ (2009) 1.01
Anti-inflammatory effects of triptolide in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2000) 1.01
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. Urology (1996) 1.01
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats. Am J Respir Crit Care Med (2001) 1.01
Assessing tumors in living animals through measurement of urinary beta-human chorionic gonadotropin. Nat Med (2000) 1.00
The Chinese version of the General Health Questionnaire: does language make a difference? Psychol Med (1985) 0.98
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status. Oncogene (2010) 0.98
Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc Natl Acad Sci U S A (1993) 0.97
Mapping the alpha-subunit site photolabeled by the noncompetitive inhibitor [3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor. J Biol Chem (1990) 0.96
Prostate-specific antigen. Its discovery and biochemical characteristics. Urol Clin North Am (1997) 0.94
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate (1995) 0.94
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. Antimicrob Agents Chemother (1999) 0.93
Actions of epimers of 12-(OH)-reduced saxitoxin and of 11-(OSO3)-saxitoxin on squid axon. Toxicon (1985) 0.93
Analyses of the NRAMP1 and IFN-gammaR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am J Respir Crit Care Med (1998) 0.93
Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer. World J Urol (1997) 0.92
Autoantibodies define a family of proteins with conserved double-stranded RNA-binding domains as well as DNA binding activity. J Biol Chem (1999) 0.92
Facets of loneliness and depression among Chinese children and adolescents. J Soc Psychol (1999) 0.90
A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2. Transplant Proc (1996) 0.90
The carboxyl-terminal transactivation domain of human serum response factor contains DNA-activated protein kinase phosphorylation sites. J Biol Chem (1993) 0.90
Cell cycle checkpoints and DNA repair in Nijmegen breakage syndrome. Clin Immunol Immunopathol (1997) 0.89
Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer. Prostate Cancer Prostatic Dis (1998) 0.89
CsA-sensitive purine-box transcriptional regulator in bronchial epithelial cells contains NF45, NF90, and Ku. Am J Physiol (1998) 0.88
Leukotriene B4 mediates histamine induction of NF-kappaB and IL-8 in human bronchial epithelial cells. Am J Physiol (1998) 0.88
Capillary prolactin measurement for diagnosis of seizures. Ann Neurol (1991) 0.88
Functional sites and transient states of the nicotinic acetylcholine receptor. Soc Gen Physiol Ser (1987) 0.87
Diaphragmatic paralysis due to Lyme disease. Eur Respir J (1999) 0.87
Conformational states in denaturants of cytochrome c and horseradish peroxidases examined by fluorescence and circular dichroism. Biochemistry (1998) 0.87